4 ms·
The article advocates conducting trials in a single country, to massively simplify the complexity. I understand the attraction, but doesn't that lead to drugs t
by roelschroeven 5y ago
The article advocates conducting trials in a single country, to massively simplify the complexity. I understand the attraction, but doesn't that lead to drugs that work fine for that population, but not for others (less effective and/or more side effects)? If I recall correctly I have recently read articles that some drugs are already too specific to one population, and not enough information is available about best treatment options for other populations.
I imagine doing trials in a single country only increases the risk of that happening.
- nineplay 5y agoCompanies would also quickly find the cheapest country to do trials in - and we can only wonder what would make it cheaper to run trials in one country vs. another. Less infrastructure, less government red tape, fewer regulations? Someplace far from watchful eyes? Fiction, obviously, but there was a John Le Carre novel where a evil drug company did secret trials in an African country because it was easier to cover up the deaths of participants.
- roelschroeven 5y ago"The Constant Gardener". I haven't read the book but I've seen the 2005 movie adaptation. I didn't know (or perhaps had already forgotten) that he movie is based on a John Le Carré novel.